Loading...
Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
SIMPLE SUMMARY: Non-clinical safety, toxicology, and pharmacokinetic studies according to ICH guidelines with a new fusion protein tTF-NGR consisting of human truncated tissue factor (TF) and a small targeting peptide are reported. Results are compared with those of a phase I clinical dose escalatio...
Saved in:
| Published in: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7759859/ https://ncbi.nlm.nih.gov/pubmed/33256235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|